Source:http://linkedlifedata.com/resource/pubmed/id/19372837
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-4-17
|
pubmed:abstractText |
Most of the studies investigating inhibition of human immunodeficiency virus integration have focused on blocking the enzymatic functions of HIV integrase, with the predominant judgment that integration inhibitors need to block at least one of the integrase-catalyzed reactions. Recent studies, however, have highlighted the importance of other proteins and their contacts with integrase in the preintegration complex, and their involvement in chromosomal integration of the viral DNA.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:status |
PubMed-not-MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1746-6318
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
380-7
|
pubmed:year |
2006
|
pubmed:articleTitle |
Integration of human immunodeficiency virus as a target for antiretroviral therapy.
|
pubmed:affiliation |
Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland 20892, USA.
|
pubmed:publicationType |
Journal Article
|